Influence of obesity on the appearance of proteinuria and renal insufficiency after unilateral nephrectomy M Praga, E Hernández, JC Herrero, E Morales, Y Revilla, ... Kidney international 58 (5), 2111-2118, 2000 | 500 | 2000 |
Clinical features and long‐term outcome of obesity‐associated focal segmental glomerulosclerosis M Praga, E Hernández, E Morales, AP Campos, MA Valero, MA Martínez, ... Nephrology Dialysis Transplantation 16 (9), 1790-1798, 2001 | 466 | 2001 |
Treatment of IgA nephropathy with ACE inhibitors: a randomized and controlled trial M Praga, E Gutiérrez, E Gonzalez, E Morales, E Hernández Journal of the American Society of Nephrology 14 (6), 1578-1583, 2003 | 464 | 2003 |
Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies E Morales, MA Valero, M León, E Hernández, M Praga American Journal of Kidney Diseases 41 (2), 319-327, 2003 | 462 | 2003 |
New tools for recombinant protein production in Escherichia coli: A 5‐year update GL Rosano, ES Morales, EA Ceccarelli Protein science 28 (8), 1412-1422, 2019 | 356 | 2019 |
ESC Council on hypertension position document on the management of hypertensive emergencies BJH van den Born, GYH Lip, J Brguljan-Hitij, A Cremer, J Segura, ... European Heart Journal–Cardiovascular Pharmacotherapy 5 (1), 37-46, 2019 | 277 | 2019 |
Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration M Praga, E Morales, JC Herrero, AP Campos, B Domínguez-Gil, R Alegre, ... American journal of kidney diseases 33 (1), 52-58, 1999 | 203 | 1999 |
Obesity, proteinuria and progression of renal failure M Praga, E Morales Current opinion in nephrology and hypertension 15 (5), 481-486, 2006 | 201 | 2006 |
SGLT-2 inhibitors and GLP-1 receptor agonists for nephroprotection and cardioprotection in patients with diabetes mellitus and chronic kidney disease. A consensus statement by … P Sarafidis, CJ Ferro, E Morales, A Ortiz, J Malyszko, R Hojs, K Khazim, ... Nephrology Dialysis Transplantation 34 (2), 208-230, 2019 | 200 | 2019 |
Factors influencing the progression of renal damage in patients with unilateral renal agenesis and remnant kidney E Gonzalez, E Gutierrez, E Morales, E Hernandez, A Andres, I Bello, ... Kidney international 68 (1), 263-270, 2005 | 183 | 2005 |
Double versus single renal allografts from aged donors A Andrés, JM Morales, JC Herrero, M Praga, E Morales, E Hernández, ... Transplantation 69 (10), 2060-2066, 2000 | 175 | 2000 |
Mutations in theCOL4A4 and COL4A3 genes cause familial benign hematuria M Praga, B Tazón, L Heidet, C Arrondel, A Armengol, A Andrés, ... Journal of the American Society of Nephrology 13 (5), 1248-1254, 2002 | 168 | 2002 |
Eculizumab in secondary atypical haemolytic uraemic syndrome T Cavero, C Rabasco, A López, E Román, A Ávila, Á Sevillano, A Huerta, ... Nephrology Dialysis Transplantation 32 (3), 466-474, 2017 | 156 | 2017 |
Remission of hematuria improves renal survival in IgA nephropathy AM Sevillano, E Gutiérrez, C Yuste, T Cavero, E Mérida, P Rodríguez, ... Journal of the American Society of Nephrology 28 (10), 3089-3099, 2017 | 153 | 2017 |
Conservative versus immunosuppressive treatment of patients with idiopathic membranous nephropathy A Torres, B Domínguez-Gil, A Carreño, E Hernández, E Morales, ... Kidney international 61 (1), 219-227, 2002 | 135 | 2002 |
Factors that determine an incomplete recovery of renal function in macrohematuria-induced acute renal failure of IgA nephropathy E Gutiérrez, E González, E Hernández, E Morales, MA Martínez, G Usera, ... CLINICAL JOURNAL-AMERICAN SOCIETY OF NEPHROLOGY 2 (1), 51, 2007 | 132 | 2007 |
From malignant hypertension to hypertension-MOD: a modern definition for an old but still dangerous emergency A Cremer, F Amraoui, GYH Lip, E Morales, S Rubin, J Segura, ... Journal of human hypertension 30 (8), 463-466, 2016 | 131 | 2016 |
Long-term renal survival in malignant hypertension R González, E Morales, J Segura, LM Ruilope, M Praga Nephrology Dialysis Transplantation 25 (10), 3266-3272, 2010 | 118 | 2010 |
Mechanisms of cardiovascular disorders in patients with chronic kidney disease: a process related to accelerated senescence J Carracedo, M Alique, C Vida, G Bodega, N Ceprián, E Morales, M Praga, ... Frontiers in cell and developmental biology 8, 185, 2020 | 103 | 2020 |
Update on lupus nephritis: looking for a new vision E Morales, M Galindo, H Trujillo, M Praga Nephron 145 (1), 1-13, 2021 | 94 | 2021 |